US Lauds India’s Cooperation in Arrest of Drug Precursor Smugglers

The US Embassy in India praised Indian law enforcement for helping disrupt a network smuggling precursor chemicals to drug cartels. The US Treasury designated Satishkumar Hareshbhai Sutaria and Yuktakumari Ashishkumar Modi for supplying fentanyl precursors to Mexico and Guatemala. The suspects used Indian pharmaceutical companies SR Chemicals and Agrat Chemicals to mislabel and ship the chemicals. Indian authorities arrested both individuals in March 2025, leading to OFAC sanctions and asset blocking.

Key Points: US Lauds India for Arrest of Drug Peddlers to Cartels

  • US Treasury designates Indian chemical suppliers for fentanyl precursor trafficking
  • Suppliers smuggled N-Boc-4-Piperidone to Mexico and Guatemala mislabeled as safe chemicals
  • Suspects Satishkumar Sutaria and Yuktakumari Modi arrested by Indian authorities in March 2025
  • OFAC blocks all US property of designated persons and entities
2 min read

US lauds Indian cooperation for arrest of 'drug peddlers' smuggling, distributing precursor chemicals to cartels

US Treasury designates Indian suppliers for fentanyl precursor smuggling to Mexico and Guatemala, lauding Indian law enforcement for arrests in March 2025.

"The United States deeply appreciates our partnership with Indian law enforcement, which was instrumental in disrupting key elements of this criminal network distributing precursor chemicals to cartels. - US Embassy in India"

New Delhi, April 29

The US Embassy in India has lauded India's cooperation in disrupting key elements of a network that were allegedly helping transport illegal drugs to the US.

The Trump administration has tightened its chokehold on drugs.

In a post on X, the US Embassy in India said, "The United States deeply appreciates our partnership with Indian law enforcement, which was instrumental in disrupting key elements of this criminal network distributing precursor chemicals to cartels that manufacture and traffic illegal drugs into the United States."

The statement said that the US Department of the Treasury's Office of Foreign Assets Control (OFAC) on April 23 designated Satishkumar Hareshbhai Sutaria for assisting in the production of illicit fentanyl.

"Today, OFAC designated Satishkumar Hareshbhai Sutaria (Sutaria), an India-based pharmaceutical chemicals supplier trading in fentanyl precursors for use in the production of illicit fentanyl. With salesperson Yuktakumari Ashishkumar Modi (Modi), Sutaria facilitates sales and shipments of these precursors to Mexico and Guatemala, including N-Boc-4-Piperidone, and mislabels them as 'safe chemicals.'," the statement read.

It further said that Sutaria's accomplice, Yuktakumari Ashishkumar Modi, used Indian pharmaceutical companies for transactions and was arrested by Indian government.

"Sutaria and Modi have used SR Chemicals and Pharmaceuticals (SR Chemicals) and Agrat Chemicals and Pharmaceuticals (Agrat Chemicals), both India-based pharmaceutical chemical companies, to conduct these transactions. Sutaria and Modi were arrested in March 2025 by Indian authorities for this activity," as per the statement.

"OFAC designated Sutaria, Modi, SR Chemicals, and Agrat Chemicals pursuant to E.O. 14059 for having engaged in, or attempted to engage in, activities or transactions that have materially contributed to, or pose a significant risk of materially contributing to, the international proliferation of illicit drugs or their means of production," the statement added.

All property and interests in property of the designated or blocked persons described above that are in the United States are blocked and must be reported to OFAC. In addition, any entities that are owned, directly or indirectly, individually or in the aggregate, 50% or more by one or more blocked persons are also blocked, the statement said.

Unless authorised by a general or specific license issued by OFAC, or exempt, OFAC's regulations generally prohibit all transactions by US persons or within (or transiting) the United States that involve any property or interests in property of blocked persons.

- ANI

Share this article:

Reader Comments

P
Priya S
But why are Indian pharmaceutical companies being used for this? Need much stricter monitoring of chemical exports. The fact that they could mislabel "safe chemicals" shows a serious loophole in our regulations.
J
James A
As an American who travels to India for work, this collaboration is excellent news. India's pharmaceutical industry is world-class - just need to ensure bad actors don't abuse it. Kudos to both governments.
V
Vikram M
Finally some real action! For years we've heard about fentanyl crisis in US, but now India is actually stepping up. Arresting these people in March shows our law enforcement means business. Well done NCB and authorities! 👏
S
Siddharth J
I appreciate the cooperation, but let's be honest - the US has a huge demand problem. They keep blaming supply chains, but maybe they should also focus on why so many Americans are turning to drugs in the first place. Still, good that India is not becoming a safe haven for criminals.
M
Michael C
My company partners with Indian pharma firms. The vast majority are ethical and follow strict protocols. These two bad actors are the exception, not the rule. Glad to see swift action.
T
Tanya I
Mislabeling chemicals as "safe" is pure criminal negligence. These people are indirectly responsible for countless overdose deaths

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50